MoneyWorks4Me

A fair growth of 9.81% in the revenue at Rs. 716.99 millions was reported in the December 2021 quarter as compared to Rs. 652.93 millions during year-ago period.An average growth of 30.16% was recorded for the quarter ended December 2021 to Rs. 79.66  millions from Rs. 61.20 millions.Operating profit for the quarter ended December 2021 rose to 132.89 millions as compared to 106.01 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 716.99 652.93 9.81 2391.39 1907.13 25.39 2474.50 3207.95 -22.86
Other Income 60.28 48.90 23.27 165.27 126.99 30.14 171.80 71.11 141.60
PBIDT 132.89 106.01 25.36 473.07 252.52 87.34 363.28 374.25 -2.93
Interest 1.04 1.72 -39.53 3.62 4.79 -24.43 6.53 7.96 -17.96
PBDT 131.85 104.29 26.43 469.45 247.73 89.50 356.75 366.29 -2.60
Depreciation 23.13 20.80 11.20 64.17 61.80 3.83 82.32 76.75 7.26
PBT 108.72 83.49 30.22 405.28 185.93 117.97 274.43 289.54 -5.22
TAX 29.06 22.29 30.37 94.46 37.41 152.50 53.01 97.85 -45.83
Deferred Tax 7.28 6.80 7.06 0.85 10.16 -91.63 9.27 -8.10 -214.44
PAT 79.66 61.20 30.16 310.82 148.52 109.28 221.42 191.69 15.51
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 18.53 16.24 14.16 19.78 13.24 49.40 14.68 11.67 25.84
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..